371 related articles for article (PubMed ID: 1677526)
1. Predicting risk of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
Rutstein RM
Am J Dis Child; 1991 Aug; 145(8):922-4. PubMed ID: 1677526
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
MMWR Recomm Rep; 1991 Mar; 40(RR-2):1-13. PubMed ID: 1672036
[TBL] [Abstract][Full Text] [Related]
3. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
[TBL] [Abstract][Full Text] [Related]
4. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
JAMA; 1991 Apr; 265(13):1637-40, 1643-4. PubMed ID: 1672167
[No Abstract] [Full Text] [Related]
5. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1.
Rigaud M; Pollack H; Leibovitz E; Kim M; Persaud D; Kaul A; Lawrence R; John DD; Borkowsky W; Krasinski K
J Pediatr; 1994 Sep; 125(3):476-80. PubMed ID: 7915306
[TBL] [Abstract][Full Text] [Related]
7. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection.
Kovacs A; Frederick T; Church J; Eller A; Oxtoby M; Mascola L
JAMA; 1991 Apr; 265(13):1698-703. PubMed ID: 1672169
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV.
Connor E; Bagarazzi M; McSherry G; Holland B; Boland M; Denny T; Oleske J
JAMA; 1991 Apr; 265(13):1693-7. PubMed ID: 1672168
[TBL] [Abstract][Full Text] [Related]
9. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Kovacs JA; Masur H
Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.
MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy in human immunodeficiency virus-infected children--a 4-year experience.
Güngör T; Funk M; Linde R; Kynast I; Allendorf A; Lotz C; Ehrenforth S; Hofmann D; Kornhuber B; Kreuz W
Eur J Pediatr; 1993 Aug; 152(8):650-4. PubMed ID: 8104791
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
14. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection.
J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):46-55. PubMed ID: 8417174
[No Abstract] [Full Text] [Related]
16. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized pentamidine. Approved for HIV-infected individuals at high risk for Pneumocystis carinii pneumonia.
Young FE; Nightingale SL; Cooper EC; Trapnell CB
Arch Intern Med; 1989 Nov; 149(11):2412-3. PubMed ID: 2818104
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children.
Goodwin SD
Pharmacotherapy; 1993; 13(6):640-6. PubMed ID: 8302691
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection.
Mueller BU; Butler KM; Husson RN; Pizzo PA
J Pediatr; 1991 Dec; 119(6):992-4. PubMed ID: 1960625
[No Abstract] [Full Text] [Related]
20. Aerosolized pentamidine: a well-tolerated mode of prophylaxis against Pneumocystis carinii pneumonia in older children with human immunodeficiency virus infection.
Orcutt TA; Godwin CR; Pizzo PA; Ognibene FP
Pediatr Infect Dis J; 1992 Apr; 11(4):290-4. PubMed ID: 1565553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
